Skip to main content
Advertisement
  • American Heart Association
  • Science Volunteer
  • Warning Signs
  • Advanced Search
  • Donate

  • Home
  • About this Journal
    • Editorial Board
    • General Statistics
    • Circulation Doodle
      • Doodle Gallery
      • Circulation Cover Doodle
    • → Blip the Doodle
    • Information for Advertisers
    • Author Reprints
    • Commercial Reprints
    • Customer Service and Ordering Information
  • All Issues
  • Subjects
    • All Subjects
    • Arrhythmia and Electrophysiology
    • Basic, Translational, and Clinical Research
    • Critical Care and Resuscitation
    • Epidemiology, Lifestyle, and Prevention
    • Genetics
    • Heart Failure and Cardiac Disease
    • Hypertension
    • Imaging and Diagnostic Testing
    • Intervention, Surgery, Transplantation
    • Quality and Outcomes
    • Stroke
    • Vascular Disease
  • Browse Features
    • AHA Guidelines and Statements
    • Bridging Disciplines
    • → Articles Bridging Discplines
    • Cardiovascular Case Series
    • Circulation Supplements
    • ECG Challenge
    • Hospitals of History
      • Hospital Santa Maria del Popolo, Naples, Italy
      • Minneapolis City Hospital
      • Pitié-Salpêtrière Hospital
      • Tufts Medical Center
      • Uppsala University Hospital
      • Vassar Brothers Medical Center (Poughkeepsie, NY)
      • Wroclaw Medical University
    • On My Mind
    • Podcast Archive
      • → Circulation on the Run, FIT Edition
    • → Subscribe to Circulation on the Run
  • Resources
    • Instructions for Authors
      • Accepted Manuscripts
      • Revised Manuscripts
    • → Article Types
    • → General Preparation Instructions
    • → Research Guidelines
    • → How to Submit a Manuscript
    • Journal Policies
    • Permissions and Rights Q&A
    • Submission Sites
    • Circulation CME
    • AHA Journals RSS Feeds
    • International Users
    • AHA Newsroom
    • Scientific Sessions 2017
  • AHA Journals
    • AHA Journals Home
    • Arteriosclerosis, Thrombosis, and Vascular Biology (ATVB)
    • Circulation
    • → Circ: Arrhythmia and Electrophysiology
    • → Circ: Cardiovascular Genetics
    • → Circ: Cardiovascular Imaging
    • → Circ: Cardiovascular Interventions
    • → Circ: Cardiovascular Quality & Outcomes
    • → Circ: Heart Failure
    • Circulation Research
    • Hypertension
    • Stroke
    • Journal of the American Heart Association
  • Facebook
  • Twitter

  • My alerts
  • Sign In
  • Join

  • Advanced search

Header Publisher Menu

  • American Heart Association
  • Science Volunteer
  • Warning Signs
  • Advanced Search
  • Donate

Circulation

  • My alerts
  • Sign In
  • Join

  • Facebook
  • Twitter
  • Home
  • About this Journal
    • Editorial Board
    • General Statistics
    • Circulation Doodle
    • → Blip the Doodle
    • Information for Advertisers
    • Author Reprints
    • Commercial Reprints
    • Customer Service and Ordering Information
  • All Issues
  • Subjects
    • All Subjects
    • Arrhythmia and Electrophysiology
    • Basic, Translational, and Clinical Research
    • Critical Care and Resuscitation
    • Epidemiology, Lifestyle, and Prevention
    • Genetics
    • Heart Failure and Cardiac Disease
    • Hypertension
    • Imaging and Diagnostic Testing
    • Intervention, Surgery, Transplantation
    • Quality and Outcomes
    • Stroke
    • Vascular Disease
  • Browse Features
    • AHA Guidelines and Statements
    • Bridging Disciplines
    • → Articles Bridging Discplines
    • Cardiovascular Case Series
    • Circulation Supplements
    • ECG Challenge
    • Hospitals of History
    • On My Mind
    • Podcast Archive
    • → Subscribe to Circulation on the Run
  • Resources
    • Instructions for Authors
    • → Article Types
    • → General Preparation Instructions
    • → Research Guidelines
    • → How to Submit a Manuscript
    • Journal Policies
    • Permissions and Rights Q&A
    • Submission Sites
    • Circulation CME
    • AHA Journals RSS Feeds
    • International Users
    • AHA Newsroom
    • Scientific Sessions 2017
  • AHA Journals
    • AHA Journals Home
    • Arteriosclerosis, Thrombosis, and Vascular Biology (ATVB)
    • Circulation
    • → Circ: Arrhythmia and Electrophysiology
    • → Circ: Cardiovascular Genetics
    • → Circ: Cardiovascular Imaging
    • → Circ: Cardiovascular Interventions
    • → Circ: Cardiovascular Quality & Outcomes
    • → Circ: Heart Failure
    • Circulation Research
    • Hypertension
    • Stroke
    • Journal of the American Heart Association

Search for author "Vojtech Melenovsky"

  • Modify Search
  • Create Alert
  • Save Search

155 Results

Type a term to search within all articles in this journal: e.g., stem cell
Content Type
Select types of content to include in the results.
Citation
Citation-specific search information
e.g., 2009
e.g., 20
e.g., 3
e.g., 29
e.g., 10.9999/123XYZ456
Authors, Keywords
Search for specific authors and/or words and phrases.
e.g., Smith, JS
e.g., Smith, JS
Type any phrase that appears in the article title
Type any phrase that appears within article title or abstract
Type any phrase that appears within article body, title or abstract
e.g., Smith, JS
Book publisher name
Limit Results
Limit search results by date
e.g., 07/22/2017
e.g., 07/22/2017
Format Results
  • You have accessRestricted access
    Evidence Supporting the Existence of a Distinct Obese Phenotype of Heart Failure With Preserved Ejection FractionClinical Perspective
    Masaru Obokata, Yogesh N.V. Reddy, Sorin V. Pislaru, Vojtech Melenovsky and Barry A. Borlaug
    Circulation. 2017;136:6-19, originally published April 5, 2017
    https://doi.org/10.1161/CIRCULATIONAHA.116.026807
    Download PDF
  • You have access
    Evidence Supporting the Existence of a Distinct Obese Phenotype of Heart Failure With Preserved Ejection FractionClinical Perspective
    Masaru Obokata, Yogesh N.V. Reddy, Sorin V. Pislaru, Vojtech Melenovsky, Barry A. Borlaug
    Circulation July 2017, 136 (1) 6-19; DOI: https://doi.org/10.1161/CIRCULATIONAHA.116.026807
    View table
    Table 1.
    By Masaru Obokata, Yogesh N.V. Reddy, Sorin V. Pislaru, Vojtech Melenovsky and Barry A. Borlaug
    Baseline CharacteristicsShow More
    Baseline CharacteristicsShow Less
  • You have access
    Evidence Supporting the Existence of a Distinct Obese Phenotype of Heart Failure With Preserved Ejection FractionClinical Perspective
    Masaru Obokata, Yogesh N.V. Reddy, Sorin V. Pislaru, Vojtech Melenovsky, Barry A. Borlaug
    Circulation July 2017, 136 (1) 6-19; DOI: https://doi.org/10.1161/CIRCULATIONAHA.116.026807
    View table
    Table 2.
    By Masaru Obokata, Yogesh N.V. Reddy, Sorin V. Pislaru, Vojtech Melenovsky and Barry A. Borlaug
    Cardiac Structure and FunctionShow More
    Cardiac Structure and FunctionShow Less
  • You have access
    Evidence Supporting the Existence of a Distinct Obese Phenotype of Heart Failure With Preserved Ejection FractionClinical Perspective
    Masaru Obokata, Yogesh N.V. Reddy, Sorin V. Pislaru, Vojtech Melenovsky, Barry A. Borlaug
    Circulation July 2017, 136 (1) 6-19; DOI: https://doi.org/10.1161/CIRCULATIONAHA.116.026807
    Figure 1.
    Figure 1.
    By Masaru Obokata, Yogesh N.V. Reddy, Sorin V. Pislaru, Vojtech Melenovsky and Barry A. Borlaug
    Body mass, cardiac remodeling, and relationships between N-terminal pro-B-type natriuretic peptide (...
    Show More
    Body mass, cardiac remodeling, and relationships between N-terminal pro-B-type natriuretic peptide (NT-proBNP) and left ventricular (LV) filling pressures. A and B, Increased body mass was associated with larger right ventricular (RV) size and total heart volume. C, Pulmonary capillary wedge pressure (PCWP) was directly correlated with NT-proBNP in all patients with heart failure with preserved ejection fraction (HFpEF), but the relationship was shifted upward in obese HFpEF, indicating a higher PCWP for any value of NT-proBNP compared with nonobese HFpEF. (D) In contrast, the correlations between LV transmural pressure (LVTMP) and NT-proBNP did not differ in obese and nonobese HFpEF.
    Show Less
  • You have access
    Evidence Supporting the Existence of a Distinct Obese Phenotype of Heart Failure With Preserved Ejection FractionClinical Perspective
    Masaru Obokata, Yogesh N.V. Reddy, Sorin V. Pislaru, Vojtech Melenovsky, Barry A. Borlaug
    Circulation July 2017, 136 (1) 6-19; DOI: https://doi.org/10.1161/CIRCULATIONAHA.116.026807
    View table
    Table 3.
    By Masaru Obokata, Yogesh N.V. Reddy, Sorin V. Pislaru, Vojtech Melenovsky and Barry A. Borlaug
    Invasive Hemodynamics at Rest and During ExerciseShow More
    Invasive Hemodynamics at Rest and During ExerciseShow Less
  • You have access
    Evidence Supporting the Existence of a Distinct Obese Phenotype of Heart Failure With Preserved Ejection FractionClinical Perspective
    Masaru Obokata, Yogesh N.V. Reddy, Sorin V. Pislaru, Vojtech Melenovsky, Barry A. Borlaug
    Circulation July 2017, 136 (1) 6-19; DOI: https://doi.org/10.1161/CIRCULATIONAHA.116.026807
    Figure 2.
    Figure 2.
    By Masaru Obokata, Yogesh N.V. Reddy, Sorin V. Pislaru, Vojtech Melenovsky and Barry A. Borlaug
    Correlations between left ventricular filling pressures, adiposity, and plasma volume. Elev...
    Show More
    Correlations between left ventricular filling pressures, adiposity, and plasma volume. Elevations in left heart filling pressures were related to greater body mass (A) and plasma volume (B) in obese heart failure with preserved ejection fraction (HFpEF) but not in nonobese HFpEF. PCWP indicates pulmonary capillary wedge pressure.
    Show Less
  • You have access
    Evidence Supporting the Existence of a Distinct Obese Phenotype of Heart Failure With Preserved Ejection FractionClinical Perspective
    Masaru Obokata, Yogesh N.V. Reddy, Sorin V. Pislaru, Vojtech Melenovsky, Barry A. Borlaug
    Circulation July 2017, 136 (1) 6-19; DOI: https://doi.org/10.1161/CIRCULATIONAHA.116.026807
    Figure 3.
    Figure 3.
    By Masaru Obokata, Yogesh N.V. Reddy, Sorin V. Pislaru, Vojtech Melenovsky and Barry A. Borlaug
    Exercise capacity and hemodynamic reserve is reduced in obese heart failure with preserved ejection...
    Show More
    Exercise capacity and hemodynamic reserve is reduced in obese heart failure with preserved ejection fraction (HFpEF). A, Compared with control subjects, the increase in cardiac index was lower in both nonobese and obese HFpEF but similar between the groups. B, The efficiency of translating metabolic work (Vo2) to external ergometric work (cycling Watts) was lower in subjects with obese HFpEF compared with nonobese HFpEF and control subjects. C, Peak Vo2 was inversely correlated with body mass. D, Peak exercise pulmonary artery mean pressure (mPAP) was higher in subjects with obese than in both subjects with nonobese HFpEF and control subjects. This was explained by impaired pulmonary vasodilation with exercise in subjects with obese HFpEF compared with both subjects with nonobese HFpEF and control subjects, evidenced by greater decreases in pulmonary artery compliance index (PACI) and less reduction in pulmonary vascular resistance index (PVRI; E and F). Error bars indicate SEM. *P<0.05 vs control subjects. †P<0.05 vs nonobese HFpEF.
    Show Less
  • You have access
    Evidence Supporting the Existence of a Distinct Obese Phenotype of Heart Failure With Preserved Ejection FractionClinical Perspective
    Masaru Obokata, Yogesh N.V. Reddy, Sorin V. Pislaru, Vojtech Melenovsky, Barry A. Borlaug
    Circulation July 2017, 136 (1) 6-19; DOI: https://doi.org/10.1161/CIRCULATIONAHA.116.026807
    Figure 4.
    Figure 4.
    By Masaru Obokata, Yogesh N.V. Reddy, Sorin V. Pislaru, Vojtech Melenovsky and Barry A. Borlaug
    Pericardial restraint and ventricular interdependence are enhanced in obese heart failure with prese...
    Show More
    Pericardial restraint and ventricular interdependence are enhanced in obese heart failure with preserved ejection fraction (HFpEF). A, Compared with patients with nonobese HFpEF and control subjects, patients with obese HFpEF displayed greater total epicardial heart volume. B, Representative short-axis echocardiographic images of the mitral valve and midcavity levels at end diastole in obese HFpEF. The septum becomes flattened and less convex to the right ventricle (RV) at end diastole, indicative of enhanced ventricular interaction. C and D, This was further supported by higher left ventricular (LV) eccentricity index and right atrial pressure (RAP)/PCWP ratio in subjects with obese HFpEF compared with nonobese HFpEF and control subjects. *P<0.05 vs control subjects. †P<0.05 vs nonobese HFpEF.
    Show Less
  • You have access
    Evidence Supporting the Existence of a Distinct Obese Phenotype of Heart Failure With Preserved Ejection FractionClinical Perspective
    Masaru Obokata, Yogesh N.V. Reddy, Sorin V. Pislaru, Vojtech Melenovsky, Barry A. Borlaug
    Circulation July 2017, 136 (1) 6-19; DOI: https://doi.org/10.1161/CIRCULATIONAHA.116.026807
    Figure 5.
    Figure 5.
    By Masaru Obokata, Yogesh N.V. Reddy, Sorin V. Pislaru, Vojtech Melenovsky and Barry A. Borlaug
    Interactions between pericardial restraint, pulmonary artery pressures, and filling pressures in sub...
    Show More
    Interactions between pericardial restraint, pulmonary artery pressures, and filling pressures in subjects with heart failure with preserved ejection fraction (HFpEF). A and B, Compared with nonobese HFpEF, left ventricular (LV) eccentricity index was greater in obese HFpEF for any given value of pulmonary artery (PA) systolic pressure both at end diastole and end systole, suggesting that septal distortion in obese HFpEF was not simply related to more right ventricular (RV) afterload mismatch. C, The increase in right atrial pressure (RAP; which approximates pericardial pressure) relative to oxygen consumption (Vo2) was greater in subjects with obese HFpEF than in both subjects with nonobese HFpEF and control subjects with exercise. D, The pulmonary capillary wedge pressure (PCWP) required to achieve any given distending LV pressure (transmural pressure [LVTMP]) was shifted upward in obese HFpEF. See text for details. *P<0.05 vs control subjects. †P<0.05 vs nonobese HFpEF.
    Show Less
  • You have accessRestricted access
    Percutaneous Pericardial ResectionCLINICAL PERSPECTIVEA Novel Potential Treatment for Heart Failure With Preserved Ejection Fraction
    Barry A. Borlaug, Rickey E. Carter, Vojtech Melenovsky, Christopher V. DeSimone, Prakriti Gaba, Ammar Killu, Niyada Naksuk, Lilach Lerman and Samuel J. Asirvatham
    Circulation: Heart Failure. 2017;10:e003612, originally published April 10, 2017
    https://doi.org/10.1161/CIRCHEARTFAILURE.116.003612
    Download PDF

Pages

  • 1
  • 2
  • 3
  • 4
  • 5
  • …
  • 16
  • Next Page
Back to top

Publication Date

Publication date

  • 2017 35
  • 2013-2016 110
  • 2008-2012 1
  • 2003-2007 9

Journal

Source

  • JAHA: Journal of the American Heart Association 10
  • Arteriosclerosis, Thrombosis, and Vascular Biology 6
  • Circulation: Heart Failure 88
  • Circulation Research 9
  • Circulation 42

Article Type

Article Type

  • ACE/Angiotension receptors 3
  • Arrhythmia/Electrophysiology 1
  • Basic Science 1
  • Brief Reviews 6
  • Cardiac Failure and Remodeling IV 1
  • Cell biology/structural biology 3
  • Cell signalling/signal transduction 3
  • Chronic ischemic heart disease 3
  • Clinical Science 3
  • Clinical Studies 3
  • Clinical Track 7
  • Clinical Trialists 1
  • Clinical genetics 3
  • Congestive 36
  • Contractile function 11
  • Core 5. Myocardium: Function and Failure 8
  • Core 5: Myocardium: Development, Function, and Failure 3
  • Correspondence 2
  • Echocardiography 10
  • Echocardiography: Novel Approaches for Assessment of LV Function I 2
  • Endothelium/vascular type/nitric oxide 3
  • Exercise testing 9
  • Exercise/exercise testing/rehabilitation 3
  • Function/Metabolism 1
  • Functional genomics 3
  • Gene expression 3
  • Gene regulation 3
  • Genetics of cardiovascular disease 3
  • Glucose intolerance 3
  • Growth factors/cytokines 3
  • Heart Failure 13
  • Heart Failure and Cardiomyopathies 2
  • Heart Failure: Pharmacologic Therapy 1
  • Hypertension - basic studies 3
  • Images in Cardiovascular Medicine 1
  • Imaging 1
  • Lipids 3
  • Mechanism of atherosclerosis/growth factors 3
  • Novel Approaches to Pharmacologic Intervention in Heart Failure 1
  • Original Article 51
  • Original Articles 35
  • Original Articles Original Article Original Articles 35
  • Original Research 10
  • Original Research Article 19
  • Other Treatment 3
  • Other Vascular biology 3
  • Other arteriosclerosis 3
  • Other diabetes 3
  • Other diagnostic testing 9
  • Other etiology 3
  • Other heart failure 10
  • Other hypertension 3
  • Oxidant stress 3
  • Pathophysiology 3
  • Physiological and pathological control of gene expression 3
  • Poster Abstract Presentations 2
  • Poster Abstract Presentations Poster Session 2 1
  • Poster Session 2 2
  • Pulmonary Hypertension: Novel Therapies and Imaging Methods 1
  • Pulmonary circulation and disease 10
  • Receptor pharmacology 3
  • Remodeling 11
  • Risk Factors 3
  • Session Title: Clinical and Hospital-Based Observational Studies II 1
  • Session Title: Heart Failure: Cardiac Mechanics and Hemodynamic Changes 1
  • Session Title: Heart Failure: Heart Failure with Preserved Ejection Fraction 1
  • Session Title: Heart Failure: Molecular Cardiology/Pathophysiology 1
  • Session Title: Heart Failure: Pathophysiology and Biomarkers 1
  • Session Title: Heart Failure: Pathophysiology and Diagnosis 1
  • Session Title: Heart Failure: Pathophysiology and Diagnosis I 1
  • Session Title: Magnetic Resonance Imaging (MRI): Heart / T1 Mapping / Spectroscopy 1
  • Session Title: Metabolic Remodeling in Heart Failure: Discoveries for Translation 1
  • Session Title: Molecular Markers of Heart Failure 1
  • Session Title: Predicting Mortality in Heart Failure 1
  • Session Title: Ventricular Function/Hemodynamics and Biomarkers 1
  • Smooth muscle proliferation and differentiation 3
  • Structure 8
  • Type 2 diabetes 3
  • Ventricular Function: Basic Mechanisms I 1
  • Volume 113, Issue 4 Supplement; August 2, 2013 / Abstracts From the American Heart Association’s Basic Cardiovascular Sciences 2013 Scientific Sessions 2
  • Volume 128, Issue 22 Supplement; November 26, 2013 / Abstracts From the American Heart Association 2013 Scientific Sessions and Resuscitation Science Symposium 4
  • Show More
  • Show Less

Subject

Subject

  • ACE/Angiotension receptors 6
  • Arrhythmias, clinical electrophysiology, drugs 1
  • CPR and emergency cardiac care 1
  • CV surgery: valvular disease 1
  • Cardiovascular Pharmacology 1
  • Cell biology/structural biology 6
  • Cell signalling/signal transduction 6
  • Chronic ischemic heart disease 6
  • Clinical Studies 6
  • Clinical genetics 6
  • Congestive 84
  • Contractile function 23
  • Echocardiography 17
  • Electrophysiology 1
  • Endothelium/vascular type/nitric oxide 6
  • Exercise 19
  • Exercise testing 28
  • Exercise/exercise testing/rehabilitation 7
  • Functional genomics 6
  • Gene expression 6
  • Gene regulation 6
  • Genetics of cardiovascular disease 6
  • Glucose intolerance 6
  • Growth factors/cytokines 6
  • Heart Failure 42
  • Hemodynamics 14
  • Hypertension 9
  • Hypertension - basic studies 6
  • Hypertrophy 1
  • Lipids 6
  • Mechanism of atherosclerosis/growth factors 6
  • Myocardial cardiomyopathy disease 10
  • Obesity 10
  • Other Treatment 6
  • Other Vascular biology 6
  • Other arteriosclerosis 6
  • Other diabetes 6
  • Other diagnostic testing 18
  • Other etiology 6
  • Other heart failure 20
  • Other hypertension 6
  • Oxidant stress 6
  • Pacemaker 1
  • Pathophysiology 20
  • Pericardial Disease 9
  • Physiological and pathological control of gene expression 6
  • Pulmonary circulation and disease 20
  • Receptor pharmacology 6
  • Remodeling 22
  • Risk Factors 6
  • Smooth muscle proliferation and differentiation 6
  • Structure 16
  • Type 2 diabetes 6
  • Valvular heart disease 1
  • Volume 113, Issue 4 Supplement; August 2, 2013 / Abstracts From the American Heart Association’s Basic Cardiovascular Sciences 2013 Scientific Sessions 2
  • Volume 128, Issue 22 Supplement; November 26, 2013 / Abstracts From the American Heart Association 2013 Scientific Sessions and Resuscitation Science Symposium 4
  • Show More
  • Show Less

Content Type

Resource Type

  • Articles 42
  • Tables & Figures 107
  • HWTABLE 6
Advertisement
Advertisement

Circulation

  • About Circulation
  • Instructions for Authors
  • Circulation CME
  • Statements and Guidelines
  • Meeting Abstracts
  • Permissions
  • Journal Policies
  • Email Alerts
  • Open Access Information
  • AHA Journals RSS
  • AHA Newsroom

Editorial Office Address:
200 Fifth Avenue, Suite 1020
Waltham, MA 02451
email: circ@circulationjournal.org
 

Information for:
  • Advertisers
  • Subscribers
  • Subscriber Help
  • Institutions / Librarians
  • Institutional Subscriptions FAQ
  • International Users
American Heart Association Learn and Live
National Center
7272 Greenville Ave.
Dallas, TX 75231

Customer Service

  • 1-800-AHA-USA-1
  • 1-800-242-8721
  • Local Info
  • Contact Us

About Us

Our mission is to build healthier lives, free of cardiovascular diseases and stroke. That single purpose drives all we do. The need for our work is beyond question. Find Out More about the American Heart Association

  • Careers
  • SHOP
  • Latest Heart and Stroke News
  • AHA/ASA Media Newsroom

Our Sites

  • American Heart Association
  • American Stroke Association
  • For Professionals
  • More Sites

Take Action

  • Advocate
  • Donate
  • Planned Giving
  • Volunteer

Online Communities

  • AFib Support
  • Garden Community
  • Patient Support Network
  • Professional Online Network

Follow Us:

  • Follow Circulation on Twitter
  • Visit Circulation on Facebook
  • Follow Circulation on Google Plus
  • Follow Circulation on Instagram
  • Follow Circulation on Pinterest
  • Follow Circulation on YouTube
  • Rss Feeds
  • Privacy Policy
  • Copyright
  • Ethics Policy
  • Conflict of Interest Policy
  • Linking Policy
  • Diversity
  • Careers

©2017 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. The American Heart Association is a qualified 501(c)(3) tax-exempt organization.
*Red Dress™ DHHS, Go Red™ AHA; National Wear Red Day ® is a registered trademark.

  • PUTTING PATIENTS FIRST National Health Council Standards of Excellence Certification Program
  • BBB Accredited Charity
  • Comodo Secured